Critical Care Drugs Market

Critical Care Drugs Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028

  • Ongoing
  • July 2020
  • REP-GB-9068
  • PDF PPT EXCEL
Critical Care Drugs Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Critical Care Drugs market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Critical Care Drugs market.

Critical Care Drugs: Market Insights

Critical care drugs are the drugs used in an emergency, which helps to treat major injuries and illness. Critical care drugs are generally used in specific care units such as intensive care unit (ICU), coronary care unit (CCU) or any other specific healthcare or trauma centre. Critical care drugs are generally used to treat major complications or they are majorly used during surgeries. There are various life-saving drugs such as adrenaline, calcium gluconate, Sodium bicarbonate etc., which are included in the critical care drugs.

Commonly used critical drugs are opioids, sedatives, benzodiazepines etc. Critical care drugs can be used for various indications such as chest pain, Cardiac arrest, injuries etc. The well-establishing healthcare infrastructure can be an important factor, which can fuel the critical care drugs market.

Critical care drugs play a major and important role in performing surgeries. In the U.S., the rate of surgeries is increasing per year, which is expected to increase the usage of critical care drugs. 

Increasing research and developmental activities and the number of clinical trials are being performed by the researchers and can lead to the development of many more new critical care drugs for some specific treatment.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Critical Care Drugs: Market Dynamics

An increasing prevalence of chronic diseases such as cardiovascular disease, brain disorders etc. is the major factors, driving the critical care drugs market. The increasing number of road accidents, leading to increased cases of injuries, is expected to increase the usage of critical care drugs. This is expected to increase the growth of the critical care drugs market. An increasing number of surgeries can also increase the growth of the critical care drugs market. Other factors such as the presence of a large number of hospitals, changing lifestyle of the people, intake of poor diet, can cause chronic disorders, which can fuel the critical care drugs market.

Side effects of the drugs or allergic reaction caused due to some of the critical care drugs can hinder the growth of critical care drugs market. Unavailability of a few critical care drugs can also hinder the growth of the critical care drugs market.

Critical Care Drugs Market: Overview

The Critical care drugs market has been segmented into opioids, Benzodiazepines, Sedatives, and Anesthetics. Apart from these drugs, there are many other critical care drugs which are used to treat chronic disorders and many complicated injuries. These critical care drugs are life-saving drugs. The critical care drugs are generally used in operation theatres and intensive care unit. Other critical care drugs include Nitroglycerine, Amlodipine, captopril, Succinyl Choline etc. Most commonly used critical care drugs are opioids and are expected to hold a large revenue share in the overall critical care drugs market. Based on the end user, operation theatres and intensive care units are expected to hold a large revenue share in the critical care drugs market.

Critical Care Drugs Market: Region-wise Outlook

On the basis of geography, the global Critical Care Drugs market has been divided into different regions viz. North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa. North America is expected to hold the largest revenue share in the global Critical Care Drugs market due to the presence of a large number of research and developmental activities and the availability of well-established healthcare infrastructure. Europe is expected to hold the second largest market share in Critical Care Drugs market due to increasing population and the presence of a large number of hospitals. However, Asia-Pacific is expected to register the fastest growth in revenue generation for Critical Care Drugs market due to a large population in countries such as Japan, China and India and also due to increasing healthcare awareness among the people and a large number of surgeries performed per year.

Critical Care Drugs Market: Key Players

Critical Care Drugs market has many key players.  Some of the key manufacturers of the global Critical Care Drugs market are Pfizer Inc., Abbott, Cadila Pharmaceutica, Triveni chemicals, Haffkine Bio-Pharmaceutical Corporation Ltd., Neon Laboratories Limited, Cambrex Corporation and many more.

The report covers exhaustive analysis on:

  • Critical Care Drugs Market Segments
  • Critical Care Drugs Market Dynamics
  • Critical Care Drugs Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Critical Care Drugs Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Critical Care Drugs Market: Segmentation

The global peri-implantitis market is segmented by drug type and end user:

Segmentation by Drug Type

  • Opoids
  • Morphine
  • Pethidine
  • Naloxone
  • Fentanyl 
  • Benzodiazepines
  • Diazepam
  • Midazolam
  • Lorazepum
  • Flumazenil
  • Sedatives
  • Anesthetics
  • Others

Segmentation by End User

  • Intensive care unit (ICU)
  • Coronary Care Unit (CCU)
  • Operation Theatres
  • Trauma Centers

Report Highlights:

  • Detailed overview of parent Critical Care Drugs market
  • Changing Critical Care Drugs market dynamics in the industry
  • In-depth Critical Care Drugs market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Critical Care Drugs Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Critical Care Drugs Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Akshay Godge

Akshay Godge

Client Partner - Global Business Development

Our Clients


Request Sample Request customization Request Methodology